Sputnik V

FDA has approved the mix & match approach for COVID vaccines

The hospital chain is all set to roll out Sputnik V vaccine pilot along with Covishield and Covaxin

Dr V K Paul, member (health), NITI Aayog said that by the first quarter of the next year, the number is likely to be three billion

As part of a limited pilot, the soft launch of the vaccine has commenced and the first dose was administered in Hyderabad today

The deal is similar to RDIF's agreements with Stelis Biopharma, Gland Pharma, and Hetero Biopharma, among others.

The rolling review will continue until enough evidence is available for formal marketing authorisation application

Dr Abdul Ghafur, Coordinator, Chennai Declaration on AMR and Consultant in Infectious Diseases, Apollo Hospital, Chennai explains…

Supplies to be facilitated by international partners of RDIF in India, China, South Korea and other countries